|
Market Closed -
Bombay S.E.
11:02:32 21/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 103.45 INR | -4.70% |
|
-6.17% | -20.42% |
| Market Cap | 1.19B 12.53M 11.17M 10.28M 9.36M 17.56M 17.86M 124M 48.85M 623M 47.02M 46.03M 1.97B | P/E 2025 |
10.7x | P/E 2026 | 12.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.99B 21.03M 18.74M 17.24M 15.7M 29.46M 29.96M 208M 81.96M 1.04B 78.88M 77.22M 3.3B | EV / Sales 2025 |
1.02x | EV / Sales 2026 | 0.92x |
| Free-Float |
14.66% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| PARNAXLAB | Delayed | |
NSE India S.E.
| PARNAXLAB | Delayed |
| 1 day | -4.70% | ||
| 1 week | -6.17% | ||
| Current month | -7.22% | ||
| 1 month | -13.18% | ||
| 3 months | -28.21% | ||
| 6 months | -33.60% | ||
| Current year | -20.42% |
| 1 week | 101.95 |  | 115 |
| 1 month | 101.95 | | 133 |
| Current year | 99.2 | | 182 |
| 1 year | 99.2 | | 182 |
| 3 years | 75.6 | | 193.5 |
| 5 years | 23.35 | | 193.5 |
| 10 years | 11.65 | | 193.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 04/07/2024 | |
Binoy Baiju Shah
DFI | Director of Finance/CFO | 42 | 04/07/2024 |
| Compliance Officer | - | 20/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ami Mihir Shah
BRD | Director/Board Member | 50 | 30/03/2015 |
| Director/Board Member | 72 | 27/05/2021 | |
| Director/Board Member | 67 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.70% | -6.17% | -21.63% | +14.44% | 12.59M | |
| +2.83% | +8.10% | +63.42% | +123.50% | 1,133B | |
| +3.81% | +5.40% | +39.47% | +74.91% | 621B | |
| +0.14% | +0.60% | +23.25% | +95.03% | 503B | |
| +0.03% | +5.72% | +39.64% | +64.06% | 379B | |
| -1.76% | -0.09% | +68.04% | +43.41% | 370B | |
| +1.58% | +5.07% | +23.26% | +51.98% | 292B | |
| +2.90% | +5.53% | +4.06% | +24.45% | 262B | |
| +2.04% | +4.97% | +48.53% | +60.42% | 237B | |
| +2.36% | +2.38% | +26.68% | +102.04% | 190B | |
| Average | +0.73% | +2.28% | +31.47% | +65.42% | 398.8B | |
| Weighted average by Cap. | +1.35% | +3.73% | +43.30% | +82.74% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.88B 19.81M 17.65M 16.24M 14.79M 27.75M 28.22M 196M 77.21M 984M 74.31M 72.75M 3.11B | 2.49B 26.22M 23.37M 21.5M 19.57M 36.73M 37.36M 260M 102M 1.3B 98.38M 96.3M 4.11B |
| Net income | 115M 1.22M 1.08M 996K 907K 1.7M 1.73M 12.03M 4.74M 60.35M 4.56M 4.46M 191M | 118M 1.24M 1.11M 1.02M 927K 1.74M 1.77M 12.3M 4.84M 61.7M 4.66M 4.56M 195M |
| Net Debt | 690M 7.28M 6.48M 5.97M 5.43M 10.19M 10.37M 72.04M 28.36M 361M 27.3M 26.72M 1.14B | 805M 8.49M 7.57M 6.97M 6.34M 11.9M 12.1M 84.1M 33.11M 422M 31.86M 31.19M 1.33B |
Employees
12
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/10/26 | ₹103.45 | -4.70% | 594 |
| 19/10/26 | ₹108.55 | -5.61% | 127 |
| 16/10/26 | ₹115.00 | +4.31% | 126 |
| 15/10/26 | ₹110.25 | 0.00% | 3 |
| 14/10/26 | ₹110.25 | -4.17% | 811 |
- Stock Market
- Stocks
- PARNAXLAB Stock
Select your edition
All financial news and data tailored to specific country editions
